Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart. | Zendy

Edward M. Gilbert | Zendy; Anthony Sandoval | Zendy; Patricia S. Larrabee | Zendy; Dale G. Renlund | Zendy; John B. OʼConnell | Zendy; Michael R. Bristow | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart.

Author(s) -

Edward M. Gilbert,

Anthony Sandoval,

Patricia S. Larrabee,

Dale G. Renlund,

John B. OʼConnell,

Michael R. Bristow

Publication year - 1993

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.88.2.472

Subject(s) - medicine , lisinopril , norepinephrine , heart failure , endocrinology , coronary sinus , angiotensin converting enzyme , adrenergic , adrenergic receptor , cardiology , angiotensin ii , ace inhibitor , receptor , blood pressure , dopamine

In subjects with heart failure, angiotensin converting enzyme inhibitors exhibit mild systemic antiadrenergic effects, as deduced from treatment-related lowering of systemic venous norepinephrine levels. The effects of angiotensin converting enzyme inhibitors on cardiac adrenergic drive in subjects with heart failure has not previously been investigated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research